1. Home
  2. VEEA vs QNTM Comparison

VEEA vs QNTM Comparison

Compare VEEA & QNTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VEEA
  • QNTM
  • Stock Information
  • Founded
  • VEEA 2014
  • QNTM 1998
  • Country
  • VEEA United States
  • QNTM Canada
  • Employees
  • VEEA N/A
  • QNTM N/A
  • Industry
  • VEEA
  • QNTM
  • Sector
  • VEEA
  • QNTM
  • Exchange
  • VEEA NYSE
  • QNTM NYSE
  • Market Cap
  • VEEA 83.9M
  • QNTM 69.3M
  • IPO Year
  • VEEA N/A
  • QNTM N/A
  • Fundamental
  • Price
  • VEEA $1.63
  • QNTM $19.31
  • Analyst Decision
  • VEEA
  • QNTM
  • Analyst Count
  • VEEA 0
  • QNTM 0
  • Target Price
  • VEEA N/A
  • QNTM N/A
  • AVG Volume (30 Days)
  • VEEA 29.9K
  • QNTM 372.2K
  • Earning Date
  • VEEA 08-23-2025
  • QNTM 08-13-2025
  • Dividend Yield
  • VEEA N/A
  • QNTM N/A
  • EPS Growth
  • VEEA N/A
  • QNTM N/A
  • EPS
  • VEEA N/A
  • QNTM N/A
  • Revenue
  • VEEA $139,252.00
  • QNTM N/A
  • Revenue This Year
  • VEEA N/A
  • QNTM N/A
  • Revenue Next Year
  • VEEA N/A
  • QNTM N/A
  • P/E Ratio
  • VEEA N/A
  • QNTM N/A
  • Revenue Growth
  • VEEA N/A
  • QNTM N/A
  • 52 Week Low
  • VEEA $1.33
  • QNTM $2.70
  • 52 Week High
  • VEEA $18.56
  • QNTM $38.25
  • Technical
  • Relative Strength Index (RSI)
  • VEEA N/A
  • QNTM 51.05
  • Support Level
  • VEEA N/A
  • QNTM $15.88
  • Resistance Level
  • VEEA N/A
  • QNTM $19.50
  • Average True Range (ATR)
  • VEEA 0.00
  • QNTM 2.55
  • MACD
  • VEEA 0.00
  • QNTM -0.55
  • Stochastic Oscillator
  • VEEA 0.00
  • QNTM 30.11

About VEEA VEEA INC

Veea Inc is a company providing an edge platform having extensive knowledge and expertise on content delivery and edge computing, and has brought a broad range of Wi-Fi, 4G/5G mobile wireless, and IoT products to market over the past two decades. The company has first-in-class VeeaHub smart connectivity and computing hubs that integrate a full range of connectivity options, application processing power, and a full security stack to form an elastic edge computing platform with a dynamic connectivity and application mesh that can easily be deployed and centrally managed from the cloud.

About QNTM QUANTUM BIOPHARMA LTD

Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, it is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, which represents loans secured by residential or commercial property.

Share on Social Networks: